The efficacy of combined treatment with recombinant human tumor necrosis factor-α and 5-fluorouracil is dependent on the development of capillaries in tumor
- 1 February 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (2) , 93-99
- https://doi.org/10.1016/0277-5379(90)90289-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Tumor necrosis factor α induces early morphologic and metabolic alterations in friend leukemia cell tumors and fibrosarcomas in miceInternational Journal of Cancer, 1988
- Anti‐tumor effects of tumor necrosis factor in combination with chemotherapeutic agentsInternational Journal of Cancer, 1987
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Recombinant human tumor necrosis factor — II. Antitumor effect on murine and human tumors transplanted in miceInternational Journal of Immunopharmacology, 1986
- Recombinant human tumor necrosis factor — I. Cytotoxic activity in vitroInternational Journal of Immunopharmacology, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984